Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Annick Le Mevel"'
Autor:
Christian Berthou, Jean-Marie Andrieu, Malika Djeridane, Eric Labouyrie, Philippe Casassus, C. Ghandour, Pierre Colonna, Thierry Lamy, Josette Brière, Vincent Delwail, Viviane Dubruille, Arash Jenabian, Yasmine Chait, Bernard Desablens, Norbert Ifrah, Annick Le Mevel, Pierre Feugier
Publikováno v:
Blood. 104(9)
Lymphocyte-predominant Hodgkin lymphoma (LPHL), according to the Revised European-American Lymphoma classification, was considered on a retrospective basis as a specific clinical entity with a large majority of patients at clinical stage (CS) IA or I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c9e1e4d5967fc86c4dd4c0f4f7e871
https://pubmed.ncbi.nlm.nih.gov/15231567
https://pubmed.ncbi.nlm.nih.gov/15231567
Autor:
Vincent Delwail, Saïd Atmani, Mahmoud Dib, Marc Bernard, Josette Brière, C. Ghandour, Christine Le Maignan, Magda Vigier, Christian Berthou, Jean-Marie Andrieu, Hervé Maisonneuve, Bernard Desablens, Annick Le Mevel, Philippe Casassus, Catherine Traulle, Pierre Colonna
Publikováno v:
Blood. 103(1)
From 1990 to 1996, a total of 386 adult patients with early/intermediate Hodgkin disease (HD) were randomly assigned to receive 3 cycles of adriamycin, bleomycin, vinblastine, dacarbazine (an alkylating agent), and methylprednisolone (ABVDm, arm A) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8760fd7c43568c909d2dd7c636ad167a
https://pubmed.ncbi.nlm.nih.gov/12907440
https://pubmed.ncbi.nlm.nih.gov/12907440